Biotech Venture Capital’s Uneasy Future–The Fed’s Impact On Innovation

With the Fed talking about raising interest rates over 200 basis points or more this summer to combat the highest inflation since the 1980s and the stock market signaling a possible recession, what lies ahead for venture managers and their companies?

Read the full post on Forbes - Healthcare